Ahmed Adam
Head Research Coordinator, County Government of Mombasa
Dr. Francis E. André✝
International Consultant in Vaccinology. Independent Consultant, Belgium
Collins Ankunda
Clinical Research Fellow at Mildmay Research Centre, Uganda
Dr. Wolfgang Bender
Managing Partner LB Life Sciences Consulting
Merle M. Böhmer
Infectious Disease Epidemiologist Bavarian Health and Food Safety Authority, Munich, Germany
Prof. Ray Borrow
Consultant Clinical Scientist, Meningococcal Reference Unit, Public Health England, Manchester, UK.
Dr. Donna Boyce
Senior Vice President Global Regulatory Affairs, Pfizer
Prof. Wilbur H. Chen
Professor, Department of Medicine, University of Maryland School of Medicine
Rachel Chihana
Principal Investigator, Johns Hopkins Research Project
Dr. Stephen Clark
Senior Scientist
Prof. Oliver A. Cornely
Professor of Infectious Diseases, Head, CECAD Cluster of Excellence, University of Cologne
Prof. Dr. Gerhard Dobler
Professor, Emerging Infections, Bundeswehr Institute of Microbiology
Dr. Alex Esteves-Jaramillo
MD, MPH
Dr. Nathalie Garçon
CEO/CSO, BIOASTER
Prof. Anne Gershon
Professor of Pediatrics, Pediatric Infectious Disease, Columbia University College of Physicians and Surgeons, Dept. Pediatrics
Dr. William Gruber
Senior Vice President, Vaccine Clinical R&D, Pfizer Vaccines, Pearl River, USA
Dr. Rosalind Hollingsworth
Senior Program Officer, Respiratory Pandemic Pathogens, Bill & Melinda Gates Foundation
Khrystyna Hrynkevych
MD, MSc in Vaccinology. Assistant to the Editor-in-Chief, Global Health Press, Singapore
Prof. Li-Min Huang
Department of Pediatrics, College of Medicine, National Taiwan University and Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University. Chief, Division of Pediatric Infectious Diseases, National Taiwan University Hospital, Taipei, Taiwan
Dr. Kathrin Jansen
PhD, Senior Vice President and Head of Vaccine R&D, Pfizer Inc
Prof. T Jacob John
Professor and Head, Departments of Clinical Virology & Microbiology, Christian Medical College (Vellore)(Retired)
Prof. Stefan H. E. Kaufmann
Max-Planck-Institute for Biophysical Chemistry, Göttingen, Germany. Max-Planck-Institute for Infection Biology, Berlin, Germany
Timothy Chege Kuria
Doctoral candidate, Friedrich-Alexander-Universität Erlangen-Nürnberg, Germany
Cara Lange
Resident and Scientific Assistant
Prof. Heidi J. Larson
The Vaccine Confidence ProjectTM and Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine
Prof. Min-Shi Lee
National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Zhunan, Taiwan
Dr. Hoe Nam Leong
Infectious disease specialist, Mount Elizabeth Novena Hospital, Singapore
Prof. Myron M. Levine
Associate Dean for Global Health, Vaccinology and Infectious Diseases, University of Maryland School of Medicine
Dr. Leesa Lin
The Vaccine Confidence ProjectTM and Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine
Prof. Chun-Jen Liu
Hepatitis Research Center, Department of Internal Medicine & Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine and Hospital
Dr. Stephen Lockhart
Vice President, Vaccine Clinical R&D, Head, Europe and Asia Pacific, Pfizer Vaccines, Hurley, UK
Dr. Jay Lucidarme
Senior Scientist
Kerstin Lühn
Compound Development Team Leader, Janssen Vaccines & Prevention B.V., Netherlands
Dr. Sultan Mahmood
ShuHaRi Health
Prof. Dr. Georg Marckmann
Director, Institute of Ethics, History and Theory of Medicine, Ludwig Maximilians University of Munich
Dr. Wolfgang Maurer
Senior Scientist (retired)
Dr. Stéphanie Meyer
Global Medical Product Leader, Dengvaxia, Sanofi Pasteur, France
Dr. Jennifer Moisi
Vice President, Global Medical Franchise Lead, Tick-Borne Disease and Enteric Vaccines
Prof. Susan M. Moore
Adjunct Professor, Department of Diagnostic Medicine/Pathobiology, Kansas State University, Manhattan, Kansas, United States
Dr. Valerie Oriol Mathieu
Global Medical Affairs Leader, Janssen Vaccines & Prevention B.V., Netherlands
Dr. Su-Peing Ng
Global Medical Head, Sanofi Pasteur, Singapore
Prof. Heikki Peltola
Professor of Infectious Diseases Emeritus, University of Helsinki
Dr. Audino Podda
GSK Vaccines Institute for Global Health
Dr. Frederick Porter
Chief Technical Officer, Taysha Gene Therapies
Prof. Marco Aurelio Palazzi Sáfadi
Professor of Pediatrics, Santa Casa de São Paulo School of Medicine, São Paulo, Brazil
Dr. Shampa Saha
Master in Vaccinology, MPH, MBBS. Vaccinologist and Public Health Specialist
Dr. Yauba Saidu
Clinton Health Access Initiative, Cameroon. Institute for Global Health, University of Siena, Italy. Africa-Editor, Global Health Press, Singapore
Dr. Melvin Sanicas
Takeda Pharmaceuticals International AG, Zurich, Switzerland. Grupo de Genética de Micobacterias, Dpto. Microbiología, Medicina Preventiva y Salud Pública, Universidad de Zaragoza, Zaragoza, España
Dr. Merlin Sanicas
Aix-Marseille University, Marseille, France, Centre de Recherche en cancérologie de Marseille – Anticorps Thérapeutiques et Immunociblage, Laboratoire Adhésion & Inflammation
Prof. Dr. Heinz Josef-Schmitt
em. Prof. of Infectious Diseases and Vaccine Development. Editor-in-Chief, Global Health Press, Singapore
Dr. Anne Schuind
Employee of PATH, Washington DC, USA; her contribution is under her own personal capacity and not as PATH representative
Prof. Dr. Werner Solbach
Center for Infection and Inflammation, University Lübeck, Germany
Prof. Dr. Robert Steffen
Epidemiology, Biostatistics and Prevention Institute, WHO Collaborating Centre on Travellers' Health, University of Zurich, Zurich, Switzerland and Department of Epidemiology, Human Genetics and Environmental Sciences, University of Texas School of Public Health, Houston TX, USA
Dr. Jeff Stoddard
Vice President Medical Affairs – Infectious Diseases and Vaccines, Janssen, USA
Prof. Igor Stoma
Rector of Gomel State Medical University, Gomel, Belarus. Professor of Infectious Diseases, M.D., D.Sc.
Prof. Dr. Thomas Szucs
Professor of Pharmaceutical Medicine, Director of The Institute of Pharmaceutical Medicine / European Center of Pharmaceutical Medicine, University of Basel
Dr. Jeffrey B. Ulmer
Consultant, Vaccines R&D
Dr. Mark van Ooij
Scientific Director – Technology Transfer, Janssen Vaccines & Prevention B.V., Netherlands
Dr. Heinz Weidenthaler
Vice President Clinical Strategy, Infectious Diseases, Bavarian Nordic
Prof. Dr. Carl Heinz Wirsing von König
Formerly HELIOS Klinikum Krefeld